Antares Vision Group and Edgyn Partner to Lead Brand Protection in the Pharma Industry
Travagliato (Brescia), 21 of June 2022
Antares Vision Group, (EXM, AV:IM) Italian multinational, leading provider in Track & Trace systems and quality control, which guarantee the transparency of products and supply chains through integrated data management and Edgyn, a leading brand protection expert provider that created the patented ADFIRMIA™ digital fingerprinting technology, today announced a strategic alliance partnership to deliver the most advanced brand protection and product authentication suite with a focus on the pharmaceutical industry.
The partnership combines the two companies’ innovative authentication and traceability technologies. Edgyn’s ADFIRMIA™ digital fingerprinting solution, which has been applied to more than 1.7 billion products since 2014, creates a unique digital fingerprint for every package, an invisible and undetectable signature based on a product’s physical characteristics. Antares Vision Group brings expertise in connecting physical products to digital infrastructures across the entire supply chain, from production and packaging lines to partner networks, with an ecosystem of solutions for product digitalization, serialization, supply chain transparency and consumer trust.
Antares Vision Group will integrate Edgyn’s ADFIRMIA™ solution within its line, cloud, and mobile applications, providing current and new customers with the most advanced authentication technology on the market, in addition to its existing traceability software.
Aurélien Tignol, EDGYN CEO, said: “The partnership comes at a pivotal time for the pharmaceutical industry; companies realized that solutions for serialization and traceability can be further empowered with authentication solutions to address the issues of counterfeiting and falsified products. Antares Vision Group, with its incredible market coverage and impeccable reputation, is the right partner to help us accelerate the deployment of our solution and provide to the pharmaceutical industry, on a global scale, the most secure, connected, and non-intrusive product identification and brand protection solution on the market
Aurélien Tignol noted that the partnership would also create new opportunities leveraging consumer engagement and patient reassurance, like encouraging people to report suspect products using an app on their smartphones. “Our ADFIRMIA™ solution and Antares Vision Group’s software capabilities will empower end users to get involved in fighting counterfeits” he said.
This partnership will take crowdsourcing to a new level — people can actually participate in making the supply chain more secure. It will also add value to pharmaceutical organizations’ logistics and brand protection initiatives.
Emidio Zorzella, Antares Vision Group CEO confirms: “Our commitment to guaranteeing safety for people, products and brands is the driving force of this partnership. Our companies are fully engaged to protect end-users, through the most innovative product authentication technology, enabling an end-to-end supply chain transparency. As partners, EDGYN and Antares Vision Group will deliver the best-in-class state of the art solution, securing the pharmaceutical supply chain, combating counterfeits and safeguarding people.”
About Antares Vision Group
Antares Vision Group is an outstanding technology partner in digitalization and innovation for companies and institutions, guaranteeing the safety of products and people, business competitiveness as well as environmental protection.
The Company provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials to production, from distribution to the consumer) through integrated data management, applying artificial intelligence and blockchain technology. The Antares Vision Group is active in Life Science (pharmaceutical, biomedical devices and hospitals) and in FMCG (Fast-Moving Consumer Goods – food, beverage, cosmetics and glass & metal container). As a world leader in Track & Trace solutions for pharmaceutical products, the Company provides major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities with solutions, monitoring their supply chains and validating product authenticity. Listed since April 2019 on the Italian Stock Exchange in the AIM (Alternative Investment Market) segment, and from 14 May 2021 in the STAR segment of the MTA (Mercato Telematico Azionario), Antares Vision Group recorded a turnover of €179 million in 2021, operates in 60 countries, employs more than 1000 people and has a consolidated network of over 40 international Partners.